Aflox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aflox

Property Description
Active Ingredient Ofloxacin (INN)
Pharmacological Class Fluoroquinolone Antibiotic
Origin / Type Synthetic
Primary Forms Tablets, IV Solution, Ophthalmic/Otic Drops
General Purpose Eliminate bacterial infections

Aflox is a prescription-only brand name for the drug entity Ofloxacin, which is a synthetic antibiotic specifically formulated to target and eliminate bacterial infections. This medication is clinically recognized as an effective broad-spectrum antimicrobial agent. Ofloxacin is scientifically classified as a fluoroquinolone antimicrobial, belonging to the second-generation quinolone family of drugs. Its general therapeutic purpose is to resolve established bacterial infections within the body.

Composition and Available Forms of Ofloxacin

The composition of this medication centers on the single active substance, Ofloxacin, a fluorinated carboxyquinolone compound manufactured through synthesis. The single-entity product design allows Ofloxacin to be incorporated into various dosage forms for systemic or localized application. These forms include oral tablets and solutions prepared for intravenous infusion. A key feature is the drug's availability in topical preparations, specifically as ophthalmic solutions (eye drops) and otic preparations (ear drops), allowing for direct delivery to external sites of infection.

General Purpose and Mechanism of Action (High-Level)

The high-level mechanism of Ofloxacin's action is fundamentally bactericidal, meaning its primary function is to actively kill bacterial cells. This effect is achieved through genetic disruption, whereby the drug interferes with the bacteria's core genetic machinery. Ofloxacin works by inhibiting two specific bacterial enzymes, DNA gyrase (Topoisomerase II) and Topoisomerase IV, which are critical for the successful replication and repair of bacterial DNA. By blocking these essential processes, Ofloxacin prevents the bacteria from multiplying and ensures the targeted breakdown of the microbial cell structure.

Regulatory References

  1. Ofloxacin - StatPearls (NCBI Bookshelf)

What side effects are possible with Aflox?

Possible Side Effects and Safety Information

The safety profile of Aflox, which contains the active substance Ofloxacin, is defined by the adverse reactions and safety statements documented in official regulatory labeling for this fluoroquinolone antibiotic. The documented effects are organized by frequency and the body system affected, consistent with regulatory guidelines.


Frequency-Based Adverse Reactions

Classification Examples of Reactions (System Organ Class)
Uncommon Headache, dizziness, nausea, vomiting, diarrhea, abdominal pain, rash (Gastrointestinal, Nervous System, Skin)
Rare Tendinitis, paresthesia, anxiety, insomnia, visual disturbances, hypersensitivity reactions (Musculoskeletal, Nervous System, Psychiatric)
Very Rare Tendon rupture, severe bullous reactions (e.g., SJS/TEN), anaphylactic reactions, severe blood disorders (Musculoskeletal, Skin, Immune, Blood)

Key Safety Considerations

Official regulatory documents highlight several serious adverse reactions. These include tendon rupture and tendinitis, which may affect any tendon but often the Achilles, and can occur rapidly or months after stopping treatment. Ofloxacin is also associated with Prolongation of the QT interval, which carries a risk for cardiac rhythm disturbances.

Population-Specific Notes: The risk of tendon disorders and Aortic Aneurysm/Dissection is explicitly noted as increased in older adults (above 60 years) and those with renal impairment. Individuals with diabetes are noted to have a risk of severe changes to blood sugar levels (hypo- or hyperglycemia).

Safety Restrictions: The systemic use of Ofloxacin is subject to restrictions for certain non-severe infections to mitigate the risk of disabling side effects. It is formally contraindicated in individuals who have had previous tendon problems related to quinolone use or a history of epilepsy.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Aflox involves taking doses higher than recommended and is associated with severe, potentially life-threatening risks. The official regulatory profile highlights three primary areas of concern that define the severity of an overdose event.


Documented Overdose Presentations

System Affected Clinical Manifestations (Symptoms)
Cardiovascular Serious Cardiac Events, including fast, irregular, or pounding heartbeat, syncope (fainting), and cardiac arrest.
Central Nervous System (CNS) CNS Depression, presenting as unresponsiveness, confusion, stupor, miosis (pinpoint pupils), and slow or shallow breathing.
Gastrointestinal Complications such as inability to urinate, severe constipation, abdominal distension, and paralytic ileus.

Required Emergency Action

Immediate medical help must be sought for any symptom of overdose, especially for fainting, rapid or irregular heartbeat, or unresponsiveness. These symptoms indicate a critical medical emergency. While supportive care is the standard treatment, official documents note that the symptoms of CNS Depression may be reversible with the administration of an antidote. Treatment focuses on managing the life-threatening symptoms and maintaining vital functions, including establishing a patent airway and monitoring vital signs.

Therapeutic Uses of Aflox

What Aflox Treats: Main Uses and Benefits

The primary role of Aflox is to provide supportive relief and help manage groups of symptoms that may become intense or disruptive to daily life. This medication is considered relevant for easing symptoms related to pain, inflammation, and fever, aligning with the general therapeutic areas of this drug category.

Aflox is commonly used to help with symptoms related to physical discomfort, such as headache, muscle soreness, and other body aches. It helps address symptom clusters related to inflammatory or irritative states, including swelling, localized tenderness, and elevated body temperature (fever). It is often applied during phases when symptoms become more noticeable and interfere with daily functioning.

The medication supports the patient during difficult episodes by helping manage groups of symptoms that may become intense or disruptive. This broad relief contributes to easing the overall symptom load and may assist with maintaining a sense of stability when symptoms are more noticeable, supporting patients during episodes of heightened discomfort.


Quick Fact: Relief for Pain, Swelling, and Fever

Regulatory References

  1. Details for: IBUPROFEN TABLETS

Eligibility and Restrictions for Use

Aflox (Ofloxacin) eligibility is strictly defined by regulatory documents, distinguishing between populations for whom use is permitted, contraindicated, or restricted.

Systemic use is contraindicated for patients with a known hypersensitivity to ofloxacin or any other fluoroquinolone antibacterial. Use is also strictly prohibited for those with a history of Myasthenia Gravis (systemic use), epilepsy, or past tendon disorders linked to previous quinolone use.

Use is absolutely prohibited based on developmental status: systemic (oral or IV) Aflox is contraindicated in both children and growing adolescents due to the risk of cartilage damage. Similarly, systemic use is contraindicated during pregnancy and for women who are breastfeeding.

For some populations, Aflox use is conditional. Patients with impaired renal function must have a mandatory dosage adjustment due to reduced drug clearance. Older adults and individuals who have received an organ transplant are identified as populations with an increased risk of tendon damage. Caution is also necessary for patients with hepatic impairment or conditions that predispose to seizures or QT interval prolongation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents require specific management strategies when Aflox is co-administered with certain medications or products, based on two primary interaction types: reduced absorption and altered physiological effects.

Interactions Affecting Absorption

Co-administration with products containing multivalent cations—such as aluminum- or magnesium-containing antacids, sucralfate, iron supplements, and zinc supplements—significantly reduces Aflox's absorption and plasma concentrations. To manage this interaction, these products must be administered at least two hours before or two hours after taking Aflox.

Interactions Affecting Cardiac and Metabolic Safety

  • Antiarrhythmics: The combination of Aflox with Class IA (e.g., quinidine, procainamide) and Class III (e.g., amiodarone, sotalol) antiarrhythmics is generally avoided due to an increased risk of QTc interval prolongation.
  • Antidiabetic Agents: Aflox may increase the hypoglycemic effect of insulin or oral antidiabetic agents, requiring close monitoring of blood glucose levels when co-administered.
  • NSAIDs: Concomitant use with non-steroidal anti-inflammatory drugs (NSAIDs), particularly Fenbufen, may increase the potential for CNS excitation and seizures, necessitating caution.
  • Other Drugs: The serum concentration of Aflox may be increased by concomitant use with cimetidine. Theophylline concentration requires monitoring when co-administered, despite limited metabolic interaction.

Mechanism of Action

Targeted Disruption of Bacterial DNA Management

Ofloxacin acts by interfering with microbial enzymes essential for survival, resulting in the failure of genetic integrity. The action is specific to the prokaryotic cell, due to the unique nature of its enzyme targets. Ofloxacin functions as an inhibitor of two bacterial enzymes, DNA gyrase (Topoisomerase II) and Topoisomerase IV, which are vital for controlling the structure, replication, and separation of the bacterial DNA. By binding to these enzymes, Ofloxacin prevents the re-ligation of the cleaved DNA strands, stabilizing the complex in a non-functional state.


Causal Cascade to Bactericidal Elimination

This domain explains the sequence from molecular blockage to the final outcome. The formation of the stalled enzyme-DNA complex causes an overwhelming accumulation of irreversible double-strand breaks across the bacterial chromosome. This genetic failure initiates active bacterial cell death, classifying the action as bactericidal, which consequently results in the elimination of the microbial load.


️ Biological Boundaries of Efficacy

The mechanism is constrained when bacteria develop mutations that structurally alter the target enzymes, reducing Ofloxacin's binding affinity. Additionally, the mechanism is limited when bacteria activate specific efflux pump systems that rapidly transport the drug out of the cell, preventing it from reaching the necessary inhibitory concentration within the cell.

Dosage and Administration Information

Official Administration Guidelines

Aflox (Ofloxacin) is administered through systemic routes (oral tablets, intravenous infusion) or localized topical routes (ophthalmic and otic drops). The specific route and form depend on the infection being treated, as outlined in the official prescribing information. Oral tablets are available in standard strengths including 200 mg, 300 mg, and 400 mg.


Dosing and Frequency Patterns

The standard systemic dosing regimen is typically twice daily (every 12 hours), although lower daily doses (less than or equal to 400 mg) may be taken as a single dose. The total daily dose for systemic use should not exceed 800 mg. Treatment duration varies significantly, ranging from as few as 3 days for uncomplicated cystitis to 6 weeks for chronic conditions like prostatitis.


Administration Conditions and Adjustments

Oral tablets may be taken with or without food. However, to ensure proper absorption, the oral dose must be separated by two hours from the intake of multivalent cation-containing products, such as antacids or mineral supplements (e.g., iron, zinc). Adequate hydration must be maintained throughout the treatment course.

Special Population Rules: For patients with impaired kidney function, the frequency of the maintenance dose is officially adjusted to once every 24 hours. In cases of severe renal impairment, the unit dose may also be halved. Due to potential effects on cartilage, Ofloxacin is generally contraindicated for use in children and growing adolescents.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aflox (Ofloxacin)


Evidence for Use in Acute Exacerbation of Chronic Bronchitis (AECB)

Research examining Aflox (Ofloxacin) for bacterial infections in the lungs, particularly during acute flare-ups of chronic bronchitis, primarily uses short-term Randomized Controlled Trials (RCTs). These studies were conducted during periods of increased symptom activity in adult populations. The research explored short-term symptom changes, monitoring two main outcomes: the clinical cure rate (how symptoms evolved in the observed populations) and the microbiological eradication rate (the absence of the targeted bacteria in follow-up culture). Studies were conducted to examine outcomes in populations where Aflox was observed alongside other standard treatments.

Studies suggest that findings describe patterns observed in the studies related to both the resolution of physical discomfort and the clearance of bacteria. This evidence contributes to understanding symptom patterns over defined time intervals, providing insight into short-term changes. Limited information is available for long-term outcomes following these short-term trials. Data are still emerging regarding the continued impact of Aflox’s use as compared to subsequently developed antibiotic treatments.


Evidence for Use in Uncomplicated Urinary Tract Infections (UTI)

The evidence base for Aflox in uncomplicated urinary tract infections (UTI) relies on Randomized Controlled Trials (RCTs) and systematic reviews that explored outcomes when Aflox was studied against other established therapies or different treatment durations. The main outcomes studied were the clinical success rate (outcomes capturing phases of heightened symptom activity) and the bacteriologic response (monitoring whether the infection-causing bacteria were cleared).

Studies report patterns related to both clinical success and bacteriologic response over defined time intervals. Research highlights changes measured during the study period for both the immediate resolution of the episode and whether the infection returned (recurrence rates). The findings described were typically based on short-term follow-up periods spanning a few weeks after the treatment interval ended.


What Is Still Uncertain About Aflox Research

Several limitations and uncertainties exist within the current evidence landscape. The evidence landscape incorporates research on the emergence of bacterial resistance, a pattern that was observed in studies involving fluoroquinolone antibiotics. This resistance means that the findings from older, successful trials may not accurately reflect how the drug performs against current, circulating bacterial strains in all regions.

Furthermore, the follow-up durations were limited in most pivotal trials, meaning data for long-term outcomes are still emerging. Comparative evidence against the newest standard-of-care antibiotics is sometimes lacking, and research does not determine whether an individual will respond similarly to the group patterns observed in the studies.

Key Studies & References Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects (MHRA Drug Safety Update)

Frequently Asked Questions (FAQ)

Common questions about Aflox (FAQ)


Q: How long does the effect of one dose of Aflox typically last?

According to the pharmacokinetic data in official regulatory documents, the drug's plasma elimination half-life is typically described as being between 5 and 8 hours. This measure indicates the time it takes for the concentration of the medication in the bloodstream to be reduced by half.


Q: Is Aflox known to cause tiredness or fatigue?

Regulatory documents mention that tiredness (sometimes called asthenia) is a possible effect of Aflox. It is officially listed as an uncommon side effect. This means that it is not among the most frequently reported adverse reactions.


Q: Are there any common side effects people report when starting Aflox?

The official product information classifies several reactions as uncommon, meaning they are observed but not frequently. These include symptoms affecting the stomach and intestines, such as nausea, vomiting, diarrhea, and abdominal pain. Headache, dizziness, and rash are also listed in this category of effects.


Q: Can Aflox cause any known changes to mood or mental state?

Official documents indicate that Ofloxacin is associated with rare psychiatric reactions. These effects can include anxiety and insomnia (difficulty sleeping). Official safety information addresses potential changes to mental state.


Q: Does Aflox interfere with birth control pills?

The drug interaction information in official regulatory documents does not list an interference between Ofloxacin and hormonal birth control pills. It is standard guidance to note all medications being used.


Q: Is Aflox safe for women who are breastfeeding?

The official prescribing information states that the systemic (oral or intravenous) use of Ofloxacin is strictly contraindicated, meaning it is prohibited, for women who are breastfeeding. This restriction is based on safety data and regulatory guidance.


Q: Can Aflox affect sleep patterns?

Yes, the official safety profile for Ofloxacin includes potential effects on sleep. Insomnia, which is difficulty falling or staying asleep, is listed in the regulatory documents as a rare side effect.


Q: Why does Aflox require close monitoring in certain patient populations?

Regulatory guidance identifies certain patient groups, such as older adults and those with impaired kidney function, as requiring attention. Monitoring is necessary to manage the risk of serious but rare side effects, such as tendon disorders. It also allows for mandatory adjustments to the prescribed dosage, which is required when kidney function is reduced.


Q: Can Aflox be used for long-term treatment?

The length of treatment with Aflox can vary significantly depending on the infection being addressed. Official administration guidelines describe treatment durations ranging from only a few days to up to six weeks for certain chronic conditions, such as prostatitis. The total length of use is defined in the official prescribing information based on the infection being treated.


Q: What foods or drinks should people be aware of when taking Aflox?

The primary consideration for oral Aflox administration is its interaction with products containing multivalent cations. The official guidance states that the drug must be taken at least two hours apart from products like antacids, iron, or zinc supplements. No other specific food or drink restrictions are generally listed in the regulatory labeling.


Q: What happens if Aflox is stopped suddenly?

Regulatory guidance strongly emphasizes the importance of completing the full duration of treatment with Aflox as prescribed by a healthcare professional. The importance of completing the full duration of treatment is emphasized by regulatory guidance to prevent the development of bacterial resistance.


Q: Is there a risk of becoming dependent on Aflox?

Aflox (Ofloxacin) is classified in regulatory documents as an antibiotic used to eliminate bacterial infections. Official regulatory warnings and precautions do not indicate that this medication carries any risk of dependence or addiction.


Q: Is Aflox safe for people with known heart conditions?

Regulatory warnings note a risk of QTc interval prolongation, which is a change in the heart's electrical activity. This carries a risk for cardiac rhythm disturbances, and caution is required for individuals with existing heart conditions. Official information includes this potential safety consideration.


Q: Why is Aflox sometimes used alongside other medications?

Ofloxacin is sometimes used at the same time as other medications, either because it is required for treating certain mixed infections or to manage specific health conditions. For example, official prescribing information notes its concomitant use with antidiabetic agents, which requires additional monitoring.


Q: How should a person plan for travel if they are taking Aflox?

Official storage requirements state that Aflox must be kept at a controlled room temperature, typically between 20^circC and 25^circC. The container must be kept tightly closed and protected from excessive heat, moisture, and freezing. These official instructions apply to storing the drug, including during travel.


Q: Is Aflox the same kind of medicine as [similar drug name]?

According to official classification, Aflox, which contains Ofloxacin, is a synthetic antibiotic. It belongs to the specific class of medicines known as fluoroquinolones. This classification defines the drug's basic mechanism and type.


Q: Is it okay to take Aflox with antacids or acid-reducing medications?

Official regulatory guidance addresses the use of Aflox with antacids containing multivalent cations (like aluminum or magnesium). To support proper absorption, regulatory guidance states these products should be administered at least two hours before or two hours after an oral dose of Aflox.


Q: Is there a list of ingredients in Aflox besides the main drug substance?

Yes, the official labeling for Aflox contains a complete description of its composition. This includes the single active drug substance, Ofloxacin, along with a list of all inactive ingredients, which are sometimes called excipients.


Q: Is Aflox associated with weight gain or weight loss?

Changes in body weight have been noted in the official regulatory documents. Both weight loss and increased weight are listed as rare or very rare side effects reported in connection with Ofloxacin use.


Q: Does Aflox affect the results of common blood tests?

The official safety profile notes rare or very rare blood disorders as possible effects of the medication. These changes include alterations to blood cell counts, which are monitored via blood tests.


Q: Is it possible to be allergic to Aflox?

Yes, the official regulatory information contraindicates (prohibits) the use of Ofloxacin in any patient with a known hypersensitivity to the drug itself or to any other medicine in the quinolone class. Hypersensitivity refers to a potential severe allergic reaction.


Q: Are there known drug-herbal supplement interactions with Aflox?

Official drug interaction information does not typically list specific interactions with herbal supplements. However, regulatory guidance suggests awareness of all concomitant use of medications, vitamins, and herbal products.


Q: Are there different strengths or forms of Aflox available?

According to official information, Aflox (Ofloxacin) is available in several forms for different types of use. These include oral tablets in various strengths, such as 200 mg, 300 mg, and 400 mg, as well as specialized preparations like intravenous solutions, eye drops (ophthalmic), and ear drops (otic).


Q: Does Aflox cause issues with liver function?

Official safety information includes rare reports of hepatic dysfunction, which refers to problems with liver function. These rare effects can manifest as increased liver enzymes or jaundice.


Q: If I miss taking Aflox, what is the usual recommendation?

If a dose is missed, official patient information often indicates that the dose may be taken as soon as possible, or if it is close to the next scheduled dose, the missed dose is skipped. Specific direction may depend on the prescribing physician.


Q: Is it normal to feel slightly dizzy after starting Aflox?

Dizziness is a potential side effect listed in the official regulatory documents for Aflox. It is classified as an uncommon reaction, meaning it is observed in some individuals but is not a frequently reported occurrence.


Q: Is Aflox known to cause stomach upset or nausea?

Yes, the official safety profile includes gastrointestinal effects such as nausea, vomiting, diarrhea, and abdominal pain. These symptoms are listed in the regulatory documents as uncommon adverse reactions.


Q: Have there been many studies done on the long-term effects of Aflox?

Official regulatory summaries of the research base describe the evidence for Aflox as being primarily derived from short-term Randomized Controlled Trials (RCTs). The evidence base often notes that follow-up periods were limited, meaning data on long-term effects are described as still emerging.

How should Aflox be stored and disposed of?

How to Store and Dispose of Aflox (Ofloxacin)

The storage and disposal of Aflox tablets must align strictly with regulatory requirements to maintain product stability and safety.

Official Storage Conditions

The medication must be stored at controlled room temperature, specifically 20 C to 25 C (68 F to 77 F). The container must be kept tightly closed and the product must be kept from freezing. Regulatory guidance also requires that the medicine be kept out of the reach of children, away from excessive heat, moisture, and direct light.

Disposal Requirements

Expired or unused Aflox should be disposed of using an official drug take-back program. If a take-back option is unavailable, the FDA-recommended alternative is to mix the non-crushed tablets with an undesirable substance, such as dirt or used coffee grounds, seal the mixture in a container, and discard it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aflox found in:

A-Z Index: